Search results for Cancer Recurrence Monitoring

Latest updates for Cancer Recurrence Monitoring

Fresh curated links around cancer recurrence monitoring are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

rna-seqblog.com /1 month ago

AI-powered, next-generation sequencing blood-based assay evaluated for detection of post-HCT relapse in AML and MDS

RNA sequencing and AI-powered blood monitoring may detect relapse earlier after hematopoietic cell transplantation, improving risk prediction in AML and myelodysplastic syndrome pa...

Read source

fiercehealthcare.com /1 month ago

How MRD Testing Is Reshaping Breast Cancer Risk Assessment

New B-59 data shows circulating tumor DNA (ctDNA) and molecular residual disease (MRD) testing can better predict recurrence risk and help guide more personalized care in TNBC.

Read source

medicalxpress.com /1 month ago

Blood-based DNA signals may help track osteosarcoma in children

Detecting whether osteosarcoma, a rare but aggressive bone cancer that most often affects children and adolescents, has returned or spread remains a major challenge for patients an...

Read source

planetayurveda.com /1 month ago

Circulating Tumor DNA (ctDNA)

Why Your Doctor Recommends Circulating Tumor DNA (ctDNA)? Everything You Should Know Abstract Tumor cells continuously shed nucleic acid fragments ... Read more The post Circulatin...

Read source

dubaihealthcareguide.com /1 month ago

Predicting Prostate Cancer Recurrence Through Power Of AI

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department...

Read source

bioengineer.org /3 days ago

Breakthrough Blood Test Paves the Way for Enhanced Cancer Care

Advancements in Cancer Detection: A Statistical Breakthrough Enables Monitoring of Tumors Using Minimal Circulating DNA Cancer detection and monitoring through blood tests, commonl...

Read source

kevinmd.com /4 days ago

Fear of cancer recurrence is a human response, not a flaw

In oncology and survivorship care, one of the most common (and often least visible) experiences patients carry is fear of recurrence. For many people, finishing treatment brings a...

Read source

healio.com /1 month ago

AI uses routine data to create biomarker for pancreatic cancer

Approximately a third of patients with pancreatic ductal adenocarcinoma do not have elevated or detectable levels of a biomarker commonly used to measure response to therapy.An AI...

Read source

healio.com /1 week ago

Trial of early cancer detection test misses primary endpoint

CHICAGO — The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed results.T...

Read source

letlifehappen.com /1 month ago

Low Breast Cancer Recurrence Rate With Radiotherapy Tailored to Nodal Response

By: Charles Bankhead From: medpagetoday.com Ten years after tailored radiotherapy (RT) for breast cancer, fewer than 3% of patients had locoregional recurrences (LRR), most during...

Read source

story.motherhood.com.my /3 weeks ago

Two in Three Early Breast Cancer Patients Fear Recurrence, Yet Low-Risk Assumptions Deter Conversations

At a Glance: One in six HR+/HER2- early breast cancer patients (Stage II & III) face risk of recurrence within 3 years¹ Novartis Malaysia... The post Two in Three Early Breast...

Read source

healio.com /1 week ago

Biomarker threshold found for worse pancreatic cancer prognosis

Patients with pancreatic cancer who have “ultra-low baseline values” of a biomarker used for prognosis have similar survival as those who have the highest levels and are considered...

Read source

fiercebiotech.com /1 month ago

Blood test powered by AI shows early promise in monitoring rare childhood cancer

A new liquid biopsy test using artificial intelligence models could help spot a rare type of bone and soft tissue cancer that predominantly affects children and adolescents.

Read source

bioengineer.org /3 weeks ago

New Blood Test Detects Tumor DNA to Guide Treatment in Advanced Cancer Cases

In a groundbreaking advancement presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026), researchers have unveiled a promising approach to tail...

Read source

healio.com /1 month ago

Strategies for clinicians to catch cancer early in young adults

SAN FRANCISCO — Breast, colorectal and prostate cancers account for most screen-detectable cancers in adults aged under 50 years, with most “unfortunately diagnosed symptomatically...

Read source

bioengineer.org /1 month ago

Nationwide Study Explores Genetic Testing to Guide Follow-Up Care in Cancer Survivors

In a groundbreaking study unveiled at the ESMO Breast Cancer 2026 congress in Berlin, researchers have illuminated a compelling opportunity to address a pivotal gap in cancer genet...

Read source

rna-seqblog.com /3 weeks ago

RNA sequencing of blood samples can monitor immune responses and help tailor treatment for high-risk patients.

RNA sequencing of blood samples may help predict immune response to chemoimmunotherapy and support more personalized treatment strategies for high-risk...

Read source

bioengineer.org /1 week ago

Study Reveals Cancer Diagnostic Delays Linked to Population-Based Screening Using Cell-Free DNA Multicancer Early Detect...

A groundbreaking investigation into the ramifications of population-based multicancer early detection (MCED) screening trials has shed new light on the nuanced interplay between en...

Read source

bioengineer.org /2 weeks ago

PERCS Initiative Advances Comprehensive Care Models for Cancer Survivors

The evolving landscape of cancer care has brought about a pressing need to refine and enhance survivorship care, particularly within the realm of primary care. Despite the fact tha...

Read source

genengnews.com /1 month ago

TRACERx MRD Results Showcase ppmSeq’s Ultra-Sensitive ctDNA Detection at AACR

Ultima Genomics will present ppmSeq MRD data at the AACR Annual Meeting, including TRACERx study findings, demonstrating ultra-sensitive whole-genome ctDNA detection at parts-per-m...

Read source

bioengineer.org /1 month ago

Amplified Sciences Initiates Patient Enrollment for PanAMP Multicenter Real-World Clinical Utility Study

Amplified Sciences Unveils PanAMP: A Pioneering Clinical Utility Study Targeting Early Detection of Pancreatic Cancer In a remarkable stride toward advancing early cancer detection...

Read source

wbrz.com /1 day ago

THURSDAY HEALTH REPORT: New research targets melanoma recurrence with mRNA vaccine and immunotherapy

Melanoma accounts for a small number of skin cancer diagnoses in the U.S. but causes the most deaths from the disease and new research suggests an mRNA vaccine could help change th...

Read source

qchron.com /1 week ago

Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant the...

Phase 3 LIBRETTO-432 results establish RET fusions alongside EGFR mutations and ALK fusions as biomarkers in early-stage lung cancer that are associated with dramatic treatment out...

Read source

bioengineer.org /1 month ago

Awakening Cancer Dormancy to Revolutionize Metastasis Therapy

Metastasis remains the chief cause of cancer-related mortality, posing a formidable challenge to effective long-term treatment. A crucial, yet often underappreciated, aspect of met...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.